The legal battle between Apple and Masimo over the blood oxygen sensor in Apple Watches intensified when Apple appealed an import ban imposed by the International Trade Commission. Masimo accused Apple of patent infringement, leading to a ban on the Apple Watch Series 9 and Ultra 2. Apple disabled the blood oxygen feature in new watches sold in the US. In court, Apple argued that the ban was unjust and pointed out that Masimo's competing device was not launched until after Apple's technology was already on the market. Masimo countered, claiming the ban was valid regardless of product completion status.
Apple's legal team presented a new line of argument, asserting that the import ban was unfair to millions of Apple Watch users affected by the prohibition.
The dispute stems from Masimo's allegations of patent infringement related to the blood oxygen sensor technology within Apple Watches.
Apple argued the ban should not apply to a product when the competing device, Masimo's W1 smartwatch, was still in the prototype stage.
Masimo's lawyer claimed that it is not necessary for a product to be finished for the ITC's ruling to be considered valid.
Collection
[
|
...
]